Showing results (351-360 of 575) with videos related to
Sort By:
Pageof 58
Journal of Neural Transmission (Vienna, Austria : 1996)|December 29, 2000
Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotectionW D Le, J Jankovic, W Xie, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1996
A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremorJ Jankovic, K Schwartz, W Clemence, et al.Physical Therapy|January 1, 1996
Cardiovascular and metabolic responses to upper- and lower-extremity exercise in men with idiopathic Parkinson's diseaseE J Protas, R K Stanley, J Jankovic, et al.Neurology|May 5, 1999
The effect of estrogen replacement on early Parkinson's diseaseR Saunders-Pullman, J Gordon-Elliott, M Parides, et al.Psychopharmacology|January 1, 1984
Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brainA Reches, H R Wagner, A I Barkai, et al.Southern Medical Journal|April 1, 1992
Low body weight in Parkinson's diseaseJ Jankovic, M Wooten, C Van der Linden, et al.Neurosurgery|March 1, 1995
Outcome after stereotactic thalamotomy for dystonia and hemiballismusF Cardoso, J Jankovic, R G Grossman, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|March 23, 2001
Switching from pergolide to pramipexole in patients with Parkinson's diseaseP A Hanna, L Ratkos, W G Ondo, et al.Neurosurgery|October 1, 1995
Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremorJ Jankovic, F Cardoso, R G Grossman, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian ratsG Pezzoli, A Zecchinelli, S Ricciardi, et al.Pageof 58